Bots, editor, reviewer, Administrators
13,941
edits
Feed:Trial Acronyms: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 199: | Line 199: | ||
"EXCEL" : "XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL)", | "EXCEL" : "XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL)", | ||
"FREEDOM" : "Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease", | "FREEDOM" : "Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease", | ||
"STOP-IT" : "Study to Optimize Peritoneal Infection Therapy", | |||
"AVERT" : "Apixaban for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients", | "AVERT" : "Apixaban for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients", | ||
"CASSINI" : "Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer", | "CASSINI" : "Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer", | ||